
Join to View Full Profile
600 N Wolfe StBaltimore, MD 21287
Dr. Rappaport is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 2023 - 2026
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2023
- University of Maryland, College ParkB.S., Bioengineering, 2009 - 2014
Publications & Presentations
PubMed
- 6 citationsChimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy.John C Flickinger Jr, Ross E Staudt, Jagmohan Singh, Robert D Carlson, Joshua R Barton
NPJ Vaccines. 2022-06-23 - 8 citationsA β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer.Jeffrey A Rappaport, Ariana A Entezari, Adi Caspi, Signe Caksa, Aakash V Jhaveri
Cellular and Molecular Gastroenterology and Hepatology. 2022-01-01 - 1 citationsGuanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.John C. Flickinger, Jeffrey A. Rappaport, Joshua R Barton, Trevor R. Baybutt, Amanda M. Pattison
Biomarkers in Medicine. 2021-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: